| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |